APA (7th ed.) Citation

Q, L., L, A., L, H., LC, W., & JL, W. (2026). Targeting the AMP-activated protein kinase pathway: The active metabolites of botanical drugs represent potential strategies for treating metabolic-associated fatty liver disease. Frontiers in pharmacology, 16, 1681880. https://doi.org/10.3389/fphar.2025.1681880

Chicago Style (17th ed.) Citation

Q, Liang, Ai L, He L, Wang LC, and Wang JL. "Targeting the AMP-activated Protein Kinase Pathway: The Active Metabolites of Botanical Drugs Represent Potential Strategies for Treating Metabolic-associated Fatty Liver Disease." Frontiers in Pharmacology 16 (2026): 1681880. https://doi.org/10.3389/fphar.2025.1681880.

MLA (9th ed.) Citation

Q, Liang, et al. "Targeting the AMP-activated Protein Kinase Pathway: The Active Metabolites of Botanical Drugs Represent Potential Strategies for Treating Metabolic-associated Fatty Liver Disease." Frontiers in Pharmacology, vol. 16, 2026, p. 1681880, https://doi.org/10.3389/fphar.2025.1681880.